Abstract
In order to update the epidemiological and mycological profile of candidaemia in Europe, the European Confederation of Medical Mycology conducted a prospective, sequential, hospital population-based study from September 1997 to December 1999. A total of 2,089 cases were documented by 106 institutions in seven European countries. Rates of candidaemia ranging from 0.20 to 0.38 per 1,000 admissions were reported. Candida albicans was identified in 56% of cases. Non-albicans Candida species were most frequently isolated from patients with haematological malignancies (65%). With increasing age, an increasing incidence of Candida glabrata was seen. The 30-day mortality rate was 37.9%. The survey results underline the burden of candidaemia in a wide range of patient populations, confirm the importance of non-albicans species, and provide baseline data for future surveillance studies at a European level.
Similar content being viewed by others
References
Jarvis WR (1995) Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20:1526–1530
Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN,Wenzel RP (1999) Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29:239–244
Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1988) Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 148:2642–2645
Wenzel RP, Edmond MB (2001) The impact of hospital acquired bloodstream infections. Emerg Infect Dis 7:174–177
Pelz RK, Lipsett PA, Swoboda SM, Diener-West M, Powe NR, Brower RG, Perl TM, Hammond JM, Hendrix CW (2000) Candida infections: outcome and attributable ICU costs in critically ill patients. J Intens Care Med 15:255–261
Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins A, Stephens DS, Baughman WS, Reingold AL, Rothrock GA, Pfaller MA, Pinner RW, Hajjeh RA (1999) The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 29:1164–1170
Sandven P (2000) Epidemiology of candidemia. Rev Iberoam Micol 17:73–81
Pfaller MA, Diekema DJ (2002) Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J Clin Microbiol 40:3551–3557
Launay O, Lortholary O, Bouges-Michel C, Jarrousse B, Bentata M, Guillevin L (1998) Candidemia: a nosocomial complication in adults with late-stage AIDS. Clin Infect Dis 26:1134–1141
Tumbarello M, Tacconelli E, De Gaetano Donati K, Morace G, Fadda G, Cauda R (1999) Candidemia in HIV-infected subjects. Eur J Clin Microbiol lnfect Dis 18:478–483
Viscoli C, Girmenia C, Marinus A, Collette L, Martino P, Vandercam B, Doyen C, Lebau B, Spence D, Krcmery V, De Pauw B, Meunier F (1999) Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin lnfect Dis 28:1071–1079
Richet H, Roux P, Des Champs C, Esnault Y, Andremont A; French candidemia study group (2002) Candidemia in French hospitals: incidence rates and characteristics. Clin Microbiol Infect 8:405–412
Grillot R (1997) Epidemiological survey of candidemia in Europe. ECMM Mycology Newsletter 0/97:12–14
Donelly SM, Sullivan DJ, Shanley DB, Coleman DC (1999) Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 145:1871–1882
Marot-Leblond A, Grimaud L, Nail S, Bouterige S, Apaire-Marchais V, Sullivan DJ, Robert R (2000) New monoclonal antibody specific for Candida albicans germ tube. J Clin Microbiol 38:61–67
Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meiss JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ (2002) Defining oportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic cell transplants: an international consensus. Clin Infect Dis 34:7–14
Bernhardt H, Zimmermann K, Sissolak D, Schutt-Gerwitt H, Schroder G, Enzensberger R, Willinger B, Weig M, Berns G, Grisold A, Seewald M, Ziegler E, Ruchel R, Burkhardt S, Sommer B, Graf B, Jahn B, Asboth F, Meyer L (2000) Epidemiological survey on candidemia in Europe: results of Germany and Austria. Rev Iberoam Micol 17 (Suppl 3):146–147
Grillot R, Faure O, Fruit J, Sendid B, Rispail P, Datry A, Biava MF, Kures L, Morin O, Toubas D, Bretagne S, Bouteille B, Lebau B, Cassaing S, Cuisenier B, Grawey I, Poirot JL, Eloy O, Kauffmann-Lacrooix C, de Champs C, Kac G, Lavarde V, Baixench M, Bougnoux ME, Lachaud L, Lamy C, Pellet E, Biondi C (2000) ECMM prospective epidemiological survey of candidemia in Europe: report from France. Rev Iberoam Micol 17 (Suppl 3):144
Klingspor L, Tornquist E, Johansson A, Petrini B, Forsum U, Hedin G (2000) ECMM’s survey of candidemia in Europe: report from Sweden. Rev Iberoam Micol 17 (Suppl 3):147
Pemán J, Cantón E, Orero A, Viudes A, Frasquet J, Gobernado M (2002) Estudio multicentrico sobre la epidemiologia de las candidemias en Espana. Rev Iberoam Micol 19:30–35
Tortorano AM, Biraghi E, Astolfi A, Ossi C, Tejada M, Farina C, Perin S, Bonaccorso C, Cavanna C, Raballo A, Grossi A, the FIMUA candidemia study group (2002) European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region. J Hosp Infect 51:297–304
Kibbler CC, Seaton S, Barnes RA, Gransden WR, Holliman RE, Johnson EM, Perry JD, Sullivan DJ, Wilson JA (2003) Manangement and outcome of bloostream infections due to Candida species in England and Wales. J Hosp Infect 54:18–24
Tortorano AM, Peman J, Faure O, Bernhardt H, Kibbler CC, Grillot R (2001). Bloodstream infections due to Candida species in AIDS patients: report of 63 episodes from the European Confederation of Medical Mycology (ECMM). Clin Infect Dis 33:1219
Tortorano AM, Peman J, Klingspor L, Bernhardt H, Kibbler C, Faure O, Biraghi E, Canton E, Zimmmermann K, Ainscough S, Grillot R (2001) Candidaemia in premature neonates. Report of 123 episodes from the ECMM working group. Mycoses 44 (Suppl 1):76
Nucci M, Colombo AL, Silveira F, Richtmann R, Salomao R, Branchini ML, Spector N (1998) Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol 19:846–850
Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT, Wenzel RP and the NEMIS Study Group (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis 33:177–186
Nucci M, Anaissie E (2001) Revisiting the source of candidemia: skin or gut? Clin Infect Dis 33:1959–1967
Wingard JR (1995) Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 20:115–125
Wingard JR, Dick JD, Merz WG, Sandford GR, Saral R, Burns WH (1982) Differences in virulence of clinical isolates of Candida tropicalis and Candida albicans in mice. Infect Immun 37:833–836
Oude Lashof AML, Donelly JP, Meis JFGM, Meer JWM, Kullberg BJ (2003) Duration of antifungal treatment and development of delayed complications in patients with candidaemia. Eur J Clin Microbol Infect Dis 22:43–48
Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE (2000) Practice guidelines for the treatment of candidiasis. Clin Infect Dis 30:662–678
Walsh TJ, Rex JH (2002) All catheter-related candidemia is not the same: assessment of the balance between the risks and benefits of removal of vascular catheters. Clin Infect Dis 34:600–602
Wold Health Organisation (2003) Atlas of health in Europe. WHO Regional Office for Europe, Copenhagen, Denmark
Acknowledgments
The ECMM Working Group consists of the following members:
France: M.-F. Biava, L. Kures, CHU Nancy; M.-E. Bougnoux, CHU Ambroise-Paré, Paris; B. Bouteille, CHU Limoges; S. Bretagne, CHU Henri Mondor, Paris Créteil; B. Cuisenier, CHU Dijon; A. Datry, CHU Pitié-Salpétrière, Paris; C. De Champs, M. Cambon, CHU Clermont-Ferrand; C. Duhamel, CHU Caen; J. Dupouy-Camet, CHU Cochin, Paris; J.-P. Gangneux, CHU Rennes; C. Kauffmann-Lacroix, CHU Poitiers; O. Eloy, CHR Versailles; J. Fruit, B. Sendid, CHU Lille; I. Grawey, CHR Colmar; G. Kac, CHU Tenon, Paris; L. Lachaud, CHU Nîmes; V. Lavarde, CHU Broussais, Paris; B. Lebeau, CHU Grenoble; M.-D. Linas, CHU Rangueuil, Toulouse; O. Morin, CHU Nantes; G. Nevez, CHU Amiens; J.-L. Poirot, CHU Saint-Antoine; H. Raberin, CHU Saint-Etienne, Paris; P. Rispail, CHU Montpellier, Paris; D. Toubas-Puygauthier, CHU Reims, Paris.
Austria: D. Sissolak, Dept. Clin. Microbiology, Vienna; B. Willinger, Dept. Clin. Microbiology, Vienna; A. Grisold, Inst. Hygiene-Microbiology, Graz; F. Asboth, Path-Bact. Institute, Vienna.
Germany: H. Schütt-Gerowitt, Inst. Med. Microbiology, Köln; G. Schröder, Inst. Med. Microbiology, Greifswald; R. Enzensberger, Dept. Clin. Microbiology, Frankfurt a. M; L. Leitritz, Max v. Pettenkofer-Institute, Munich; M. Weig, Inst. Hygiene-Microbiology, Würzburg; G. Berns, Inst. Med. Microbiology, Dusseldorf; M. Seewald, Inst. Med. Diagnostic, Berlin; E. Ziegler, Inst. Pathology Barmherzigen Schwestern v. Hl. Kreuz, Wels; R. Rüchel, Inst. Hygiene, Göttingen; S. Burkhardt, Inst. Med. Microbiology, Munich; B. Sommer, Community Lab. Medicine, Potsdam; B. Graf, Inst. Microbiology-Hygiene (Charité), Berlin; B. Jahn, Inst. Microbiology- Hygiene, Mainz; L. Meyer, Children’s Clinic, Mainz.
Italy: C. Agrappi, Ospedale, Legnano; M. Arghittu, Ospedale Predabissi, Melegnano; A. Astolfi, Ospedale Niguarda Ca’ Granda, Milan; C. Bezzi, Ospedale, Magenta; C. Bonaccorso, Ospedale Sacco, Milan; S. Bramati, Ospedale S. Gerardo, Monza; P. Casella, Ospedale, Vimercate; C. Cavanna, IRCCS Ospedale San Matteo, Pavia; A. Ceraminiello, Ospedale, Lodi; L. Colombo, Ospedale, Desio; C. Farina, Ospedali Riuniti, Bergamo; L. Ferrari, Istituti Ospedalieri, Cremona; S. Frugoni, Pio Albergo Triulzio, Milan; L. Garlaschi, Istituti Clinici di Perfezionamento, Milan; G. Gialluca, Ospedale, Rho; A. Grossi, Ospedale, Treviglio; S. Gualterotti, Ospedale Bassini, Cinisello Balsamo; G. Lombardi, Ospedale Circolo, Varese; A. Mauri, Ospedale S. Paolo, Milan; M.G. Musmanno, Ospedale, Saronno; C. Ossi, IRCCS Ospedale San Raffaele, Milan; R. Passerini, Istituto Europeo Oncologia, Milan; S. Perin, Ospedale S. Carlo, Milan; S. Pierdomenico, Ospedale, Busto Arsizio; G. Pinsi, Spedali Civili, Brescia; P. Porri, Ospedale, Voghera; A. Raballo, Ospedale Poma, Mantova; A. Rigoni, IRCCS Ospedale Maggiore, Milan; R. Sala, Ospedale, Merate; M. Saudelli, Ospedale Fatebenefratelli, Milan; M. Spinelli, Ospedale S. Anna, Como; C. Sturla, Ospedale S. Antonio, Gallarate; M. Tejada, Istituto Policlinico S. Donato, S. Donato Milanese; P. Troupioti, Ospedale, Sondalo; G. Viola, Istituto Nazionale Tumori, Milan; A. Lizioli, L. Merlino, Regione Lombardia, Direzione Generale Sanità.
Spain: A. Viudes, H. LaFe, Valencia; A. Planes, H. Vall dHebrón, Barcelona; E. Cañas, H. Virgen Rocío, Seville; A. del Palacio, H. 12deOctubre, Madrid; J. Sevillano, C M Povisa, Vigo; J. Viñuelas, H. S Pedro de Alcántara, Cáceres; M. Elía, H. U., Elche; M. Giménez, H. Germans, Trías i Pujol; M. Pazo, H. Carlos Haya, Málaga; J.J. García, H. de Navarra, Pamplona; J.J. Palomar, H. General, Albacete; J.M. Hernández-Molina, H. La Inmaculada, Huercal-Overa; E. Mínguez, H. Canalejo, A Coruña; J.A. Martínez, H. Clinic, Barcelona; I. Fernández, H. de León, León; J. Martínez, H. Virgen de la Salud, Toledo; M.J. Tapiol, H. Joan XXIII, Tarragona; M.S. Cuétara, H. Severo Ochoa, Leganés; S. Giner, H. Dr Moliner, Bétera.
Sweden: E. Törnquist, Örebro Medical Center Hospital, Örebro; B. Petrini, Karolinska Hospital, Stockholm; U. Forsum, Linköping University Hospital, Linköping; G. Hedin, Central Hospital, Västerås.
UK: R.A. Barnes, University of Wales College of Medicine, Cardiff; W.R. Gransden, Guys and St Thomas’s Hospital, London; R.E. Holliman, St Georges Hospital, London; J.D. Perry, Freeman Hospital, Newcastle Upon Tyne; J.A. Wilson, Hull PHLS, Hull.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Tortorano, A.M., Peman, J., Bernhardt, H. et al. Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study. Eur J Clin Microbiol Infect Dis 23, 317–322 (2004). https://doi.org/10.1007/s10096-004-1103-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-004-1103-y